What Researchers Did
Researchers conducted a retrospective study involving 154 patients to assess the effectiveness of bacterial immunotherapy (BIT) as a preoperative treatment for chronic osteomyelitis (COM).
What They Found
After a mean follow-up of 40.4 months, healing was achieved in 41.6% of cases. Patient clinical status was the most significant prognostic factor, with a 62% healing rate in patients with normal clinical conditions (Group A) compared to 20% in those with compromised status (Group B), and 0% in Group C.
What This Means for Canadian Patients
This study suggests bacterial immunotherapy could be a viable preoperative treatment option for Canadian patients with chronic osteomyelitis, particularly those with an uncompromised clinical status. However, its application should be critically evaluated for patients with altered clinical conditions.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a retrospective study, it is limited by its observational design, potential for selection bias, and lack of a randomized control group.